Based on the forecasted data, Hepatitis B immunisation in China is projected to maintain a stable rate of 99.1% to 99.2% from 2024 through 2028. This stability is indicative of a successful and well-maintained immunisation programme. Comparatively, the immunisation rate in 2023 was slightly higher, standing at 99.2%. Thus, the year-on-year variation from 2023 to 2024 shows a marginal decrease of 0.1 percentage points.
Year-on-year analysis exhibits a consistent trend with negligible variations, as the forecast remains at 99.1% from 2025 to 2028. Given the uniform trend, the Compound Annual Growth Rate (CAGR) over the last five years is effectively flat, displaying minimal fluctuations.
Future trends to watch for include the impact of public health policies, potential outbreaks, the incorporation of new vaccines, and overall healthcare advancements that could influence vaccination rates. Additionally, tracking any shifts in public perception regarding vaccinations, as well as changes in birth rates, could provide further context for future forecasting.
